Psychiatry / Tardive Dyskinesia

Central Dopamine Blockade in the Pathophysiology of Tardive Dyskinesia

expert roundtables by Leslie Citrome, MD, MPH; Andrew J. Cutler, MD; and Rakesh Jain, MD, MPH

Dopamine receptor–blocking agents (DRBAs) are thought to lead to the development of tardive dyskinesia (TD) through mechanisms that involve postsyn......READ MORE

Tardive Dyskinesia

Practice Guidelines on Tardive Dyskinesia

expert roundtables by Leslie Citrome, MD, MPH; Andrew J. Cutler, MD; and Rakesh Jain, MD, MPH

Tardive Dyskinesia

Antipsychotic Switching Strategies in Tardive Dyskinesia

clinical topic updates by Andrew J. Cutler, MD

LATEST IN Psychiatry

Browse More Articles